Pashtoon Kasi/LinkedIn
Jan 21, 2025, 14:12
Pashtoon Kasi about targeting BRAFV600E in Colorectal Cancer
Pashtoon Kasi, Medical Director of GI Medical Oncology at City of Hope, posted on X:
“BRAFV600E is present in about 10% of patients with Colorectal Cancer.
Important to recognize since treatment and strategies might differ. Two trials have shown the addition of immunotherapy to the targeted therapies as promising.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 16, 2025, 21:51
Aug 16, 2025, 21:38
Aug 16, 2025, 21:05
Aug 16, 2025, 20:40
Aug 16, 2025, 20:27
Aug 16, 2025, 20:22